Mosquito and Mammalian Cells Grown on Microcarriers for Four Serotype Dengue Virus Production: Variations in Virus Titer, Plaque Morphology, and Replication Rate

Biotechnology and Bioengineering

Volumn 85, Issue 5, 2004, Pages 482-488

  Liu, Chia Chyi ^a   Wu, Suh Chin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Dengue virus; Microcarrier; Mosquito cells; Plaque heterogeneity; Vero cells

Indexed keywords

APPROXIMATION THEORY; CELL CULTURE; INFORMATION ANALYSIS; MORPHOLOGY; PRODUCTION; VACCINES; VIRUSES;

MAMMALIAN CELL LINES; T-FLASK CULTURE;

BIOTECHNOLOGY;

ANIMAL CELL; ARTICLE; BIOTECHNOLOGY; CELL GROWTH; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DEVICE; GENETIC VARIABILITY; HEMORRHAGIC SHOCK; MAMMAL CELL; MICROCARRIER CULTURE; MOSQUITO; NONHUMAN; SEROTYPE; VERO CELL; VIRAL GENETICS; VIROGENESIS; VIRUS MORPHOLOGY; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CERCOPITHECUS AETHIOPS; COCULTURE TECHNIQUES; CULICIDAE; DENGUE VIRUS; PLAQUE ASSAY; SEROTYPING; VERO CELLS; VIRUS CULTIVATION; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP; MAMMALIA;

EID: 1442328097     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10918     Document Type: Article

References (28)

1. Berry JM, Barnabe N, Coombs KM, Butler M. 1999. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol Bioeng 62:12-19.
2. Bhamarapravati N, Sutee Y. 2000. Live attenuated tetravalent dengue vaccine. Vaccine 18(suppl 2):44-47.
3. Blaney JE, Johnson DH, Manipon GG, Firestone C-Y, Hanson CT, Murphy BR, Whitehead SS. 2002. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 300:125-139.
4. Chen WJ, Chen SL, Fang AH. 1994. Phenotypic characteristics of Dengue 2 virus persistently infected in a C6/36 clone of Aedes albopictus cell. Intervirology 37:25-30.
5. Chun BH, Park SY, Moon HM. 1996. Production of live attenuated varicella-zoster virus in human embryonic lung cells using microcarrier. Biotechnol Techn 10:151-156.
6. Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR, Thumar B, Men R, Lai C-J, Elkins WR, Chanock RM, Murphy BR, Whitehead SS. 2001. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 65:405-413.
7. Eigen M. 1993. Viral quasispecies. Sci Am 269:42-49.
8. Gubler DJ. 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11:480-496.
9. Guirakhoo F, Arroyo J, Pugachev KV, Miller C, Zhang Z-X, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Soike K, Ratterree M, Monath TP. 2001. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol 75:7290-7304.
10. Guirakhoo F, Pugachev KV, Arroyo J, Miller C, Zhang Z-X, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Draper K, Monath TP. 2002. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology 298:146-159.
11. Halstead SB. 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 239:476-481.
12. Henchal EA, Putnak JR. 1990. The dengue viruses. Clin Microbiol Rev 3:376-396.
13. Huang CY-H, Butrapet S, Pierro DJ, Chang G-JJ, Hunt AR, Bhamarapravati N, Gubler DJ, Kinney RM. 2000, Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus a sa potential candidate dengue type 1 virus vaccine. J Virol 74:3020-3028.
14. Ikonomou L, Drugmand J-C, Gastin G, Schneider Y-J, Agathos SN. 2002. Microcarrier culture of Lepidopteran cell lines: Implications for growth and recombinant protein production. Biotechnol Progr 18:1345-1355.
15. Kinney RM, Butrapet S, Chang G-JJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ. 1997. Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230:300-308.
16. Lai C-J, Zhao BT, Hori H, Bray M. 1991. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci USA 88:5139-5143.
17. Lai C-J, Bray M, Men R, Cahour A, Chen W, Kawano H, Tadano M, Hiramatsu K, Tokimatsu I, Pletnev A, Arakai S, Shameem G, Rinaudo M. 1998. Evaluation of molecular strategies to develop a live dengue vaccine. Clin Diagn Virol 10:173-179.
18. Lazar A, Silberstein J, Reuveny S, Mizrahi A. 1987. Microcarriers as a culturing system of insect cells and insect viruses. Dev Biol Stand 66:315-323.
19. Levenbook IS, Petriccian JC, Elisberg BL. 1984. Tumorigenicity of Vero cells. J Biol Stand 12:391-398.
20. Men R, Bray M, Clark D, Chanock RM, Lai C-J. 1996. Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: Analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J Virol 70: 3930-3937.
21. Mendonca RZ, Ioshimoto LM, Mendoca RMZ, de-Franco M, Valentini EJG, Becak W, Raw I, Pareira CA. 1993. Preparation of human rabies vaccine in Vero cell culture using a microcarrier system. Braz J Med Biol Res 26:1305-1317.
22. Montagnon B, Vincent-Falquet JC, Fanget B. 1984. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine: Promising results. Dev Biol Stand 55:37-38.
23. Moran E. 1999. A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine. Cytotechnology 29:135-148.
24. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. 1998. Dengue and dengue haemorrhagic fever. Lancet 352: 971-977.
25. Sidorenko ES, Dorofeeval LV, Kaptsova TI, Steinberg LL, Zasorina IN, Sinitsyna OA, Boriskin YS. 1989. Experimental-scale measles and mumps vaccine production on microcarrier-grown cells. Vaccine 7: 554-556.
26. Wang W-K, Lin S-R, Lee C-M, King C-C, Chang S-C. 2002. Dengue type 3 virus in plasma is a population of closely related genomes: Quasi-species. J Virol 76:4662-4665.
27. Wu S-C, Huang GY-L. 2002. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Biotechnol Progr 18:124-128.
28. Zecchini TA, Smith RJ. 1999. Production of high titer disabled infectious single cycle (DISC) HSV from a microcarrier culture. Cytotechnology 30:203-210.